Mr. Min-Young Kim serves as Chief Executive Officer and Inside Director at Dong-A ST Co., Ltd. since 28 March 2022. He had been Executive Director of Management & Planning Division at Dong-A Socio Holdings...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Min-Young Kim	CEO & Inside Director	2.3yrs	데이터 없음	0.036% ₩ 199.8m
Sung-Keun Lee	CFO & Executive Director	4.3yrs	데이터 없음	데이터 없음
Hak-Jun Kim	Independent Outside Director	4.3yrs	데이터 없음	데이터 없음
Bum-Joon Kim	Independent Outside Director	2.3yrs	데이터 없음	데이터 없음
Jae-Hong Park	Inside Director	2.3yrs	데이터 없음	데이터 없음

2.3yrs

평균 재임 기간

경험이 풍부한 이사회: A170900 의 이사회는 경험(평균 재직 기간 2.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Dong-A ST 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

High number of new directors

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Less than half of directors are independent

Dong-A ST Co., Ltd. to Report Q1, 2024 Results on May 02, 2024

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Full year 2023 earnings released: EPS: ₩1,311 (vs ₩1,606 in FY 2022)

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Dong-A ST Co., Ltd., Annual General Meeting, Mar 26, 2024

Price target increased by 7.6% to ₩77,624

Now 22% overvalued after recent price rise

Dong-A ST Co., Ltd. to Report Fiscal Year 2023 Results on Feb 15, 2024

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara

Upcoming dividend of ₩686 per share at 1.1% yield

New minor risk - Profit margin trend

Investor sentiment improves as stock rises 21%

New minor risk - Share price stability

Investor sentiment improves as stock rises 28%

Dong-A ST Co., Ltd. to Report Q2, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar

Full year 2022 earnings released: EPS: ₩1,606 (vs ₩1,519 in FY 2021)

Dong-A ST Co., Ltd. Demonstrates Therapeutic Equivalence Between DMB-3115 and Stelara in Global Phase III

Upcoming dividend of ₩1,000 per share

High number of new directors

Price target decreased to ₩77,200

Price target decreased to ₩95,667

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of ₩1,000 per share

Price target decreased to ₩105,000

Does Dong-A ST (KRX:170900) Have A Healthy Balance Sheet?

Dong-A ST's (KRX:170900) Problems Go Beyond Weak Profit

Full year 2020 earnings released: EPS ₩3,212 (vs ₩8,404 in FY 2019)

A Look At The Fair Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dong-A ST Co., Ltd., Annual General Meeting, Mar 24, 2021

New 90-day low: ₩82,100

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Dong-A ST Co., Ltd. Completes the Proof-Of-Concept Study for ‘DA-1241,’ an Investigational First-In-Class Small Molecule with Mechanism of GPR119 Agonist Under Clinical Development, in Patients with Type 2 Diabetes

Dong-A ST Co., Ltd. to Report Fiscal Year 2020 Results on Feb 03, 2021

New 90-day low: ₩82,500

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Upcoming Dividend of ₩1,000 Per Share

New 90-day low: ₩83,800

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

A Look At Dong-A ST's (KRX:170900) Share Price Returns

New 90-day low: ₩85,000

New 90-day high - ₩104,500

Dong-A ST Co., Ltd. to Report First Half, 2020 Results on Jul 29, 2020

CEO

테뉴어

이사회 구성원

평균 재임 기간